NQR-25424-90325 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-01
Dose 1 — Moderna
2021-11-29
Dose 2 — Moderna
2022-06-28
Registered in v-safe
2022-11-29
Survey response — 12 months, dose 2, under 3
MedDRA: Conjunctivitis, Influenza, Streptococcal infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Strep x2 Conjunctivitis x2 Flu A x1

MedDRA releases: 2024-11 · check-in free text available
2022-11-29
Report sent to call center — 12 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-01	Moderna	No
2	2021-11-29	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — 12 months, dose 2, under 3

2022-11-29

Symptoms: Strep x2 Conjunctivitis x2 Flu A x1

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Influenza	·	·	✓
SD	Streptococcal infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release